GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (OTCPK:EBOSF) » Definitions » Degree of Financial Leverage

Ebos Group (Ebos Group) Degree of Financial Leverage : 0.50 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ebos Group Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Ebos Group's Degree of Financial Leverage for the quarter that ended in Dec. 2023 was 0.50. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Ebos Group's Degree of Financial Leverage or its related term are showing as below:

EBOSF's Degree of Financial Leverage is ranked better than
80.85% of 94 companies
in the Medical Distribution industry
Industry Median: 1.03 vs EBOSF: 0.50

Ebos Group Degree of Financial Leverage Historical Data

The historical data trend for Ebos Group's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Degree of Financial Leverage Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 0.82 1.05 0.28 0.39

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.28 0.24 0.39 0.50

Competitive Comparison of Ebos Group's Degree of Financial Leverage

For the Medical Distribution subindustry, Ebos Group's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group's Degree of Financial Leverage Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Ebos Group's Degree of Financial Leverage falls into.



Ebos Group Degree of Financial Leverage Calculation

Ebos Group's Degree of Financial Leverage for the quarter that ended in Dec. 2023 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( 0.906 (Dec. 2023) / 0.866 (Dec. 2022) - 1 )/( 302.909 (Dec. 2023) / 270.623 (Dec. 2022) - 1 )
=0.0462/0.1193
=0.39***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Ebos Group  (OTCPK:EBOSF) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Ebos Group Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Ebos Group's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (Ebos Group) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (Ebos Group) Headlines

From GuruFocus

Half Year 2024 EBOS Group Ltd Earnings Call Transcript

By GuruFocus Research 02-28-2024